Figure 2From: CHD1L Protein is overexpressed in human ovarian carcinomas and is a novel predictive biomarker for patients survival Survival curve for 102 ovarian carcinoma patients according to CHD1L protein expression status (log-rank test). Overall survival, probability of survival of all patients with ovarian carcinoma: negative expression, n=50; positive expression, n=52.Back to article page